Use of preclinical models for malignant pleural mesothelioma. (2021)
Attributed to:
EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.65431
Publication URI: https://www.repository.cam.ac.uk/handle/1810/318315
Type: Journal Article/Review